Wave Life Sciences (WVE) Amortizatization of Intangibles (2019 - 2026)
Wave Life Sciences' (WVE) quarterly Amortizatization of Intangibles came in at $1.5 million in Q2 2026, up 13.52% YoY from $1.3 million in Q2 2025, and up 3.21% on a QoQ basis from $1.5 million in Q1 2026.
Analysis
Wave Life Sciences (WVE) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 8 years of Amortizatization of Intangibles data on file, last reported at $1.5 million in Q2 2026.
- Quarterly Amortizatization of Intangibles rose 13.52% year-over-year to $1.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.8 million (up 13.55% YoY) and the FY2025 annual result came in at $5.4 million, up 13.53% from the prior year.
- Amortizatization of Intangibles improved to $1.5 million in Q2 2026, from $1.5 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.5 million in Q2 2026 to a low of $784000.0 in Q1 2022.
- A 5-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles jumped 75.27% — and 2023, when it gained 10.68%.
- Tracing WVE's Amortizatization of Intangibles over 5 years: stood at $983000.0 in 2022, then advanced by 12.0% to $1.1 million in 2023, then grew by 13.44% to $1.2 million in 2024, then grew by 13.53% to $1.4 million in 2025, then rose by 6.56% to $1.5 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Wave Life Sciences | 994.54 Mn | 626.53 Mn | - | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 983,000.00 |
| Sep 30, 2022 | 964,000.00 |
| Jun 30, 2022 | 809,000.00 |
| Mar 31, 2022 | 784,000.00 |
| Dec 31, 2021 | 759,000.00 |
| Sep 30, 2021 | 550,000.00 |